HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

HLB Pharmaceutical Statistics

Total Valuation

KOSDAQ:047920 has a market cap or net worth of KRW 218.92 billion. The enterprise value is 206.57 billion.

Market Cap	218.92B
Enterprise Value	206.57B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:047920 has 14.04 million shares outstanding.

Current Share Class	14.04M
Shares Outstanding	14.04M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.66%
Owned by Insiders (%)	11.17%
Owned by Institutions (%)	3.71%
Float	7.18M

Valuation Ratios

The trailing PE ratio is 463.17.

PE Ratio	463.17
Forward PE	n/a
PS Ratio	6.06
PB Ratio	12.23
P/TBV Ratio	12.54
P/FCF Ratio	n/a
P/OCF Ratio	161.77
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 67.05, with an EV/FCF ratio of -4,716.42.

EV / Earnings	437.04
EV / Sales	5.72
EV / EBITDA	67.05
EV / EBIT	143.36
EV / FCF	-4,716.42

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.74.

Current Ratio	1.26
Quick Ratio	1.01
Debt / Equity	0.74
Debt / EBITDA	4.28
Debt / FCF	-301.34
Interest Coverage	1.21

Financial Efficiency

Return on equity (ROE) is 2.71% and return on invested capital (ROIC) is 3.23%.

Return on Equity (ROE)	2.71%
Return on Assets (ROA)	2.19%
Return on Invested Capital (ROIC)	3.23%
Return on Capital Employed (ROCE)	6.33%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.88
Inventory Turnover	3.27

Taxes

Income Tax	-595.69M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.32% in the last 52 weeks. The beta is 0.37, so KOSDAQ:047920's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-20.32%
50-Day Moving Average	14,187.80
200-Day Moving Average	19,453.10
Relative Strength Index (RSI)	65.65
Average Volume (20 Days)	143,212

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:047920 had revenue of KRW 36.10 billion and earned 472.66 million in profits. Earnings per share was 34.13.

Revenue	36.10B
Gross Profit	18.04B
Operating Income	1.44B
Pretax Income	-123.03M
Net Income	472.66M
EBITDA	3.08B
EBIT	1.44B
Earnings Per Share (EPS)	34.13

Balance Sheet

The company has 15.16 billion in cash and 13.20 billion in debt, giving a net cash position of 1.96 billion or 139.93 per share.

Cash & Cash Equivalents	15.16B
Total Debt	13.20B
Net Cash	1.96B
Net Cash Per Share	139.93
Equity (Book Value)	17.90B
Book Value Per Share	1,292.83
Working Capital	5.93B

Cash Flow

In the last 12 months, operating cash flow was 1.35 billion and capital expenditures -1.40 billion, giving a free cash flow of -43.80 million.

Operating Cash Flow	1.35B
Capital Expenditures	-1.40B
Free Cash Flow	-43.80M
FCF Per Share	-3.12

Margins

Gross margin is 49.98%, with operating and profit margins of 3.99% and 1.31%.

Gross Margin	49.98%
Operating Margin	3.99%
Pretax Margin	-0.34%
Profit Margin	1.31%
EBITDA Margin	8.53%
EBIT Margin	3.99%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:047920 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.30%
Shareholder Yield	-2.30%
Earnings Yield	0.22%
FCF Yield	-0.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 12, 2016. It was a forward split with a ratio of 1.5.

Last Split Date	Apr 12, 2016
Split Type	Forward
Split Ratio	1.5

Scores

KOSDAQ:047920 has an Altman Z-Score of 2.49 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.49
Piotroski F-Score	6